Neoadjuvant intensity modulated radiotherapy for a single and small (≤5 cm) hepatitis B virus-related hepatocellular carcinoma predicted to have high risks of microvascular invasion: a randomized clinical trial

医学 肝细胞癌 四分位间距 随机对照试验 新辅助治疗 临床终点 内科学 放射治疗 胃肠病学 外科 阶段(地层学) 肿瘤科 癌症 乳腺癌 生物 古生物学
作者
Xu‐Biao Wei,Yabo Jiang,Shuang Feng,Chongde Lu,Lei Huo,Bin Zhou,Yan Meng,Wan Yee Lau,Yaxin Zheng,Shuqun Cheng
出处
期刊:International Journal of Surgery [Wolters Kluwer]
卷期号:109 (10): 3052-3060 被引量:9
标识
DOI:10.1097/js9.0000000000000574
摘要

The presence of microvascular invasion (MVI) significantly impairs postoperative long-term survival of patients with hepatocellular carcinoma (HCC). The role of neoadjuvant radiotherapy (RT) in treating patients with an early-stage HCC predicted to have high risks of MVI remains to be explored.Consecutive patients with a resectable single and small (≤5 cm) hepatitis B virus-related HCC predicted to have high risks of MVI were randomized 1:1 to receive either neoadjuvant intensity modulated radiation therapy (18 Gy with fractionated doses of 3 Gy) followed by surgery 4 weeks later or upfront surgery. The primary endpoint was disease-free survival (DFS). The secondary outcomes included overall survival (OS), objective response rate, RT-related toxicity and surgical complications.There were 30 patients randomized to each of the two groups. In the neoadjuvant RT group, three patients violated the study protocol, with two having upfront hepatectomy and one radiofrequency ablation after RT. The objective response rate after RT was 25.0% (7/28), but 2 patients suffered from grade 3 liver toxicity. The median follow-up was 68 months (interquartile range, 58-70 months) in the neoadjuvant RT group, and 68 months (interquartile range, 62-75 months) in the upfront surgery group. On intention-to-treat analysis, the median DFS and median OS were not reached in both the 2 arms. The 1-year, 2-year, 3-year and 5-year DFS rates for the neoadjuvant RT group were 86.7%, 76.7%, 60.0% and 56.3%, versus 90.0%, 66.7%, 52.8% and 45.7% in the upfront surgery group ( P =0.448), respectively. The corresponding OS rates were 96.7%, 86.7%, 83.3% and 72.7%, versus 100.0%, 93.3%, 79.6% and 60.7% ( P = 0.399).For patients with a resectable single and small hepatitis B virus-related HCC predicted to have high risks of MVI, neoadjuvant RT gave a promising response rate with a mild toxicity. Nevertheless, the neoadjuvant RT yielded similar long-term DFS and OS rates compared with patients who underwent upfront surgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
und发布了新的文献求助50
1秒前
1秒前
明天剪纸发布了新的文献求助10
1秒前
万能图书馆的应助被22x采纳,获得10
2秒前
2秒前
月见黑完成签到,获得积分10
2秒前
3秒前
豆豆完成签到,获得积分10
3秒前
归尘发布了新的文献求助10
4秒前
5秒前
nandiaozhimu完成签到,获得积分10
5秒前
5秒前
6秒前
羔羔羊发布了新的文献求助10
6秒前
心心子完成签到 ,获得积分10
6秒前
6秒前
苹果大王完成签到 ,获得积分10
7秒前
7秒前
7秒前
7秒前
冠心没有病完成签到,获得积分10
10秒前
whoare发布了新的文献求助10
10秒前
12秒前
小二郎的应助被呆小仙采纳,获得10
13秒前
科研通AI6.2的应助被SJJ采纳,获得10
13秒前
xx发布了新的文献求助10
14秒前
脑洞疼的应助被xueee采纳,获得10
14秒前
曾许京城第一流完成签到,获得积分10
15秒前
科研通AI6.2的应助被Aniya采纳,获得10
16秒前
学术混子完成签到,获得积分10
17秒前
周澍完成签到,获得积分10
18秒前
link完成签到 ,获得积分10
18秒前
18秒前
19秒前
Garcia完成签到,获得积分10
19秒前
秋枫冬雪完成签到,获得积分10
19秒前
20秒前
20秒前
爱笑的啤酒完成签到,获得积分10
20秒前
zombie发布了新的文献求助10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153509
求助须知:如何正确求助?哪些是违规求助? 9550216
关于积分的说明 21697167
捐赠科研通 7742065
什么是DOI,文献DOI怎么找? 3425525
关于科研通互助平台的介绍 2550636
邀请新用户注册赠送积分活动 2469175